Curative Biosciences, Inc.
CBDX
$0.0001
$0.000.00%
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Net Income | -518.10K | -490.10K | -45.40K | -53.20K | -81.10K |
| Total Depreciation and Amortization | 2.60K | 2.80K | 2.80K | 2.80K | 2.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 441.80K | 441.80K | 16.50K | 37.50K | 29.90K |
| Change in Net Operating Assets | -8.20K | -6.90K | 300.00 | 100.00 | 30.90K |
| Cash from Operations | -81.80K | -52.30K | -25.70K | -12.80K | -17.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.50K | -- | -- | -- | -- |
| Cash from Investing | -12.50K | -- | -- | -- | -- |
| Total Debt Issued | 95.30K | 52.30K | 25.70K | 12.80K | 17.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 95.30K | 52.30K | 25.70K | 12.80K | 17.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.00K | -- | -- | -- | 0.00 |
